Modulatory Effects of Dabigatran on PAR-1 Activity and Viability in Adipose-Derived Mesenchymal Stem Cells
International Journal of Molecular Sciences · 24.04.2026 · 27 (9) · 3783
DOI: 10.3390/ijms27093783 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.04.2026. Verfasst von Emre Kubat und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Özel İskenderun Gelişim Hospital, 31200 Hatay, Türkiye. Hauptthemen laut MEDLINE: Dabigatran, Mesenchymal Stem Cells, Receptor, PAR-1, Antithrombins. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Protease-activated receptor-1 (PAR-1) is a key regulator of mesenchymal stem cell (MSC) migration and tissue integration. Dabigatran, a direct thrombin inhibitor widely used as a non-vitamin K oral anticoagulant (NOAC), may affect PAR-1-mediated signaling pathways. This study investigated the effects of dabigatran on cell viability, apoptosis, and PAR-1 activity in adipose-derived MSCs (ADMSCs) in vitro. ADMSCs were exposed to five concentrations of dabigatran etexilate with thrombin activation. Cell viability was assessed using the MTT assay, apoptosis and morphological changes were evaluated via acridine orange/propidium iodide staining, and PAR-1 expression was analyzed by immunofluorescence. Results showed that high dabigatran concentration significantly reduced cell viability and induced apoptotic morphological changes. In contrast, lower, non-cytotoxic concentrations preserved normal fibroblastic morphology and maintained cell viability while reducing PAR-1 surface expression compared with thrombin-activated controls. These findings indicate that dabigatran at non-cytotoxic doses can modulate PAR-1 activity without compromising ADMSC survival. In conclusion, dabigatran influences MSC-related cellular functions beyond its anticoagulant properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Özel İskenderun Gelişim Hospital, 31200 Hatay, Türkiye.
- Department of Biology, Faculty of Science, Hacettepe University, 06800 Ankara, Türkiye.
- Department of Cardiovascular Surgery, Gulhane Training and Research Hospital, University of Health Sciences, 06010 Ankara, Türkiye.
ORCID-Profile: Emre Kubat, Özer Aylin Gürpınar, Tayfun Özdem
Zitieren
APA
Kubat, E., Gürpınar, Ö. A., & Özdem, T. (2026). Modulatory Effects of Dabigatran on PAR-1 Activity and Viability in Adipose-Derived Mesenchymal Stem Cells. International Journal of Molecular Sciences, 27(9), 3783. https://doi.org/10.3390/ijms27093783
Vancouver
Kubat E, Gürpınar ÖA, Özdem T. Modulatory Effects of Dabigatran on PAR-1 Activity and Viability in Adipose-Derived Mesenchymal Stem Cells. International Journal of Molecular Sciences. 2026;27(9):3783. doi:10.3390/ijms27093783
BibTeX
@article{Kubat2026,
author = {Kubat, Emre and Gürpınar, Özer Aylin and Özdem, Tayfun},
title = {Modulatory Effects of Dabigatran on PAR-1 Activity and Viability in Adipose-Derived Mesenchymal Stem Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {9},
pages = {3783},
doi = {10.3390/ijms27093783}
}
EUVIMED